Assessing Safety, Tolerability, And Efficacy Of Subcutaneous Epcoritamab In Novel Combinations With Anti-Neoplastic Agents In Patients With Non-Hodgkin Lymphoma In A Phase 1B/2, Open-Label Study
Epcoritamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Assessing Safety, Tolerability, And Efficacy Of Subcutaneous Epcoritamab In Novel Combinations With Anti-Neoplastic Agents In Patients With Non-Hodgkin Lymphoma In A Phase 1B/2, Open-Label Study ### Output: Epcoritamab